B ijan Tehrani is an Iranian-American businessman and investor with a deep background in the life sciences and biotechnology sectors. He has been involved in the founding and financing of numerous successful healthcare companies. His wealth has grown through his role as a key executive and shareholder in several publicly traded biopharmaceutical firms.

Tehrani is known for his operational expertise, having served as President, CEO, and Chairman of companies like Immune Therapeutics. His focus has often been on acquiring and developing novel therapies for various diseases. His investment strategy involves identifying promising biopharmaceutical assets and providing the leadership and capital needed to bring them through clinical development and to the market. His career reflects a successful blend of scientific understanding and financial acumen in the high-stakes world of drug development.